The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Deep learning to predict treatment response of immune checkpoint inhibitors from pretreatment chest X-rays in non–small-cell lung cancer.
 
Woochan Hwang
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Dong Young Jeong
No Relationships to Disclose
 
Laurent Dillard
Employment - Lunit
Stock and Other Ownership Interests - Lunit
Patents, Royalties, Other Intellectual Property - Lunit
 
Chang Ho Ahn
Employment - Lunit
Stock and Other Ownership Interests - Lunit
Patents, Royalties, Other Intellectual Property - Deep learning model of IHC images providing single cell level continuous quantification of target expression
 
Sehhoon Park
Stock and Other Ownership Interests - Uppthera
Honoraria - AstraZeneca; Boehringer Ingelheim; Boryung; Bristol-Myers Squibb; Daiichi Sankyo; IMBdx; Merck; MSD; Roche; Takeda; Yuhan
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Boryung; Bristol-Myers Squibb; Daiichi Sankyo; IMBDx; Merck; MSD; Roche; Takeda; Yuhan
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Boryung; Bristol-Myers Squibb; Daich-Sankyo; IMBdx; IQVIA; Merck; MSD; Roche; Takeda; Yuhan
Research Funding - Amgen; AstraZeneca; Merck; MSD; Yuhan
 
Se-Hoon Lee
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol Myers Squibb Foundation; Lilly; Merck Sharp & Dohme; Roche; Yuhan
Consulting or Advisory Role - Abion; AstraZeneca; BeiGene; BMS/Ono; Daiichi Sankyo; IMBdx; ImmuneOncia; Janssen; Lilly; Merck (German); Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Abion
Research Funding - AstraZeneca (Inst); Daiichi Sankyo; Lunit (Inst); Merck Sharp & Dohme (Inst)
 
Chan-Young Ock
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit; Y-Biologics
Consulting or Advisory Role - De novo biotherapeutics; GCCELL; Genome & Company; Idience; Medpacto; PIN therapeutics; Selecxine; Y-Biologics
 
Ho Yun Lee
Stock and Other Ownership Interests - Cirelinesoft co
Consulting or Advisory Role - Roche
Research Funding - AstraZeneca; Bracco Diagnostics; Johnson & Johnson Inc; Lunit